Introduction
Surgical outcome after temporal lobectomy has been extensively investigated, but not in relation to seizure freedom off antiepileptic drugs (AEDs). In the most widely used outcome classification (Engel Classification), 1 class I (excellent) outcome includes patients with persistent non-disabling auras and patients with atypical seizures in conjunction with AED withdrawal. Little is known about seizure-free rates with AED withdrawal, and predictors of successful AED discontinuation. Yet, one important goal of many patients is to discontinue seizure medications. Patients who become seizure-free off AEDs can potentially be considered cured. We reviewed our series of patients who underwent temporal resections for epilepsy to identify those who were able to successfully discontinue antiepileptic drugs. We also investigated factors that may predict ability to stop AEDs successfully. 2 
Methods
We reviewed our epilepsy surgery database for all patients who underwent surgery for temporal lobe epilepsy. These included all patients operated between 1988 and 1999. Our institutional protocol is to consider medication withdrawal after 2 years of seizure freedom postoperatively, if the patient is Seizure (2007) Summary Data are limited on seizure recurrence after antiepileptic drug (AED) discontinuation in operated seizure-free patients. We reviewed seizure outcome in patients who came off AEDs after being seizure-free for 2 years following temporal lobe surgery in our center. Thirty-nine (68%) of 57 patients who discontinued AED therapy remained seizure-free. They had a younger age at surgery than the group with seizure recurrence ( p = 0.01). Earlier surgery may be a favorable predictor for seizure freedom after AED discontinuation. willing to accept some risk of seizure recurrence. Medications were tapered gradually over at least 1-2 months (but taper could be considerably slower). In patients taking more than one AED, one AED is tapered and completely removed before the taper of the other AED is initiated.
We identified patients who came off AEDs after being seizure-free for at least 2 years and reviewed seizure outcome after AED withdrawal. We analyzed age at seizure onset, duration of epilepsy before surgery, type of surgery, side of surgery, age at surgery, epilepsy risk factors, and nature of the epileptogenic lesion on MRI. The follow-up data were collected from medical records and we also attempted to contact patients by phone when follow-up data were missing. We entered all the data in a computerized database. Patients with successful AED withdrawal and those with recurrent seizures were compared for factors described above using either t-test for continuous variables or Chi-square for categorical variables. The procedures were approved by the Vanderbilt Institutional Review Board.
Results

Surgery and surgical outcome
During the study period (between 1988 and 1999), 150 patients had temporal lobe epilepsy surgery, 66 on the left and 84 on the right. Two patients had repeat surgery (one left and one right), for a total of 152 resective procedures. One hundred and twentyfour patients had standard tailored temporal lobectomies. The rest had more limited resections (extension of previous lobectomy, 2 patients; amygdalohippocampectomy, 12; amygdalohippocampectomy after lateral resection, 1; lesionectomy, 10; lesionectomy and partial lobectomy, 1; lesionectomy and amygdalohippocampectomy, 2). At last follow-up (mean 6 years), 105 patients had class I seizure outcome (Table 1) .
AED discontinuation
Fifty-seven patients discontinued AED therapy and had follow-up data. The minimum duration of follow-up after AED discontinuation was 1 year. Thirtynine (68%) of the 57 patients had no seizure recurrence after discontinuation. The successful group had a younger age at surgery than the group with seizure recurrence (Table 2 ). This was statistically significant (two-tailed t-test, p < 0.01). No other significant differences were found in the parameters examined (Table 2) . Two patients who successfully discontinued AEDs had continued to have seizures in the initial postoperative period (they were classified Engel II and III), but later became seizure-free for 2 years. One patient who had a seizure recurrence was in Engel class II during the early postoperative period. All other patients were in class I outcome throughout their postoperative course on AEDs.
Forty-three patients with class I outcome at 2 years did not come off AEDs. The main reason was persistence of auras or evidence of residual seizure tendency (such as occurrence of atypical seizure with missing medication doses). Eight patients with class IA outcome did not come off AEDs. The main reason was follow-up by another physician who did not suggest the option of AED withdrawal (4 patients). Two of these had benign tumors and were followed by a neuro-oncologist. Three patients did not want to take the risk of seizure recurrence. Two of these were also using AEDS for other reasons (neuropathic pain and mood control). The remaining patient with musicogenic epilepsy had an occipital lesion that may have accounted for rare visual seizures. She had a temporal lobectomy which eliminated her habitual complex partial seizures, but as the occipital lesion was not removed, AEDS were not stopped due to the risk of visual seizure recurrence.
Outcome after seizure recurrence
Among the 18 patients who had seizure recurrence, 14 became seizure-free again after AED reinstitution, and 2 have developed refractory epilepsy. Their ages at surgery were 56 and 42. The remaining two patients have chosen to stay off AEDs despite recurrence of seizures, because their recurrent seizures were mild and they disliked the adverse effects of AEDs.
Discussion
The main finding of this study is that approximately two-thirds of patients who came off AEDS after 2 years without seizures remained seizure-free. This percentage is similar to published reports in adults, 3, 4 but less than in one series in children. 5 This difference between adults and children is consistent with our second important finding, that patients who remained seizure-free after AED discontinuation had a lower mean age at surgery than patients who had seizure recurrence. This relationship between age at surgery and successful AED discontinuation is supported by other studies, including one study of long-term outcome that did not specifically analyze AED discontinuation. 3, 6 In our study, the duration of epilepsy was not statistically different for the groups with and without seizure recurrence, even though the mean duration of epilepsy tended to be longer for the group with seizure recurrence after AED withdrawal (Table 2) . A possible contributing factor is that the age at onset also tended to be later in that group. One study in patients with mesial temporal sclerosis and another that included all operated patients found that the duration of epilepsy was a predictor of long-term outcome. 7, 8 Other studies did not find a relationship between age at surgery and long-term outcome. 9, 10 It is possible that seizure freedom on AEDs and continued seizure freedom after AED withdrawal have different predictors. This would not be surprising, as seizure freedom on AEDs could just reflect that epilepsy has become responsive to pharmacotherapy, while continued seizure freedom after AED withdrawal may indicate cure from epilepsy.
We found no difference in the underlying pathology between the groups with and without seizure recurrence after AED discontinuation. The two main categories of mesial temporal sclerosis and foreign tissue lesions were equally represented in both groups of patients. Mesial temporal sclerosis was the most common pathology, present in 67% of patients with and 64% without seizure recurrence. Foreign tissue lesions were present in 24% of those with recurrence and 21% of those without. Similarly, the surgical approach was not a factor. Thus, it appears that for patients who are seizure-free after surgery, the above factors are not important in the prediction of seizure freedom after AED withdrawal.
The majority of patients with seizure relapse after AED discontinuation became seizure-free again. Two patients (14%) developed refractory epilepsy. Refractory epilepsy may develop after AED withdrawal in up to 23% of general epilepsy patients who were previously seizure-free. 11 The percentage again seems to be smaller in pediatric patients. 12 It is not clear if the refractory epilepsy is related to AED withdrawal, or whether it was going to develop anyway, independent of AED changes. In one study, there was no difference between AED withdrawal and AED continuation groups with respect to the risk of relapse, suggesting that relapse was not causally related to AED withdrawal. 13 This issue cannot be resolved properly without a prospective controlled study.
The possible development of refractory epilepsy could be the most potent argument against AED withdrawal following epilepsy surgery. Until this question is clarified, it is wise to counsel our patients that if seizures recur following AED withdrawal they could be difficult to control in some patients. Nevertheless, new progress in pharmacotherapy may improve outcome in patients whose relapsing seizures appear medication resistant. 14, 15 
